Patient preference« Back to Glossary Index
More formally the U.S. Food and Drug Administration (FDA) defines patient preference as a statement of the relative desirability or acceptability to patients of specified alternatives or choice among outcomes or other attributes that differ among alternative health interventions.
U.S. Food and Drug Administration (FDA) Patient-Focused Drug Development Glossary
NCATS Toolkit for Patient-Focused Therapy Development: Perform Patient Preference Studies
U.S. Food and Drug Administration (FDA): Patient Preference Information – Voluntary Submission, Review in Premarket Approval Applications, Humanitarian Device Exemption Applications, and De Novo Requests, and Inclusion in Decision Summaries and Device Labeling